Among those is polo‐like kinase 1 (PLK1), which is overexpressed in cancer, leading to MAPK‐activated protein kinases 2 (MK2)‐dependent phosphorylation and inactivation of the mRNA decay‐promoting protein, tristetraprolin. This evidence concerns the gene PLK1 and cancer.